Q2 EPS Forecast for Phibro Animal Health Raised by Analyst

Phibro Animal Health Corporation (NASDAQ:PAHC) – Stock analysts at Zacks Research upped their Q2 2027 earnings per share estimates for shares of Phibro Animal Health in a research report issued to clients and investors on Friday, September 18th. Zacks Research analyst Team now anticipates that the company will earn $0.95 per share for the quarter, up from their prior estimate of $0.85. The consensus estimate for Phibro Animal Health’s current full-year earnings is $3.50 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q3 2027 earnings at $0.82 EPS, Q4 2027 earnings at $0.90 EPS, FY2027 earnings at $3.46 EPS, Q1 2028 earnings at $0.83 EPS, Q2 2028 earnings at $1.01 EPS, Q3 2028 earnings at $0.90 EPS, Q4 2028 earnings at $0.92 EPS, FY2028 earnings at $3.65 EPS and FY2029 earnings at $3.87 EPS.

Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Phibro Animal Health in a research report on Friday, September 11th. One equities research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus target price of $47.67.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC opened at $34.68 on Monday. Phibro Animal Health has a 52 week low of $28.25 and a 52 week high of $60.08. The stock has a market capitalization of $1.41 billion, a P/E ratio of 14.21, a PEG ratio of 1.00 and a beta of 0.46. The firm has a fifty day simple moving average of $35.59 and a two-hundred day simple moving average of $40.45. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.14. The company had revenue of $396.75 million for the quarter, compared to analysts’ expectations of $381.18 million. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 2nd will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 2nd. This represents a $0.48 dividend on an annualized basis and a yield of 1.4%. Phibro Animal Health’s payout ratio is 19.67%.

Institutional Investors Weigh In On Phibro Animal Health

Several institutional investors have recently made changes to their positions in PAHC. Renaissance Technologies LLC grew its holdings in Phibro Animal Health by 5.8% during the 1st quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock valued at $31,899,000 after purchasing an additional 31,435 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Phibro Animal Health by 3.2% during the first quarter. Dimensional Fund Advisors LP now owns 507,852 shares of the company’s stock valued at $28,086,000 after buying an additional 15,517 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of Phibro Animal Health by 145.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 286,172 shares of the company’s stock valued at $15,671,000 after buying an additional 169,628 shares during the period. Capricorn Fund Managers Ltd grew its stake in shares of Phibro Animal Health by 45.1% during the first quarter. Capricorn Fund Managers Ltd now owns 267,045 shares of the company’s stock valued at $14,770,000 after buying an additional 82,944 shares during the last quarter. Finally, Ranger Investment Management L.P. bought a new position in shares of Phibro Animal Health during the second quarter valued at approximately $9,182,000. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation is a global animal-health and nutrition company that develops, manufactures and markets products intended to support the health, productivity and well-being of food-producing animals and companion animals. Its customers include livestock producers, veterinarians, feed manufacturers and distributors.

The company’s product portfolio includes vaccines, medicated feed additives, nutritional specialties, mineral and vitamin premixes, feed additives and other products used in poultry, swine, cattle, aquaculture and companion-animal applications.